Trial Profile
Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Dwarfism; Growth disorders
- Focus Therapeutic Use
- Sponsors GeneScience Pharmaceuticals
- 15 Dec 2014 New trial record